Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Aikins, M. E., J. Bazzill, and J. J. Moon. Vaccine nanoparticles for protection against HIV infection. Nanomedicine 12:673–682, 2017.
2. Apellániz, B., and J. L. Nieva. The use of liposomes to shape epitope structure and modulate immunogenic responses of peptide vaccines against HIV MPER. Advances in Protein Chemistry and Structural Biology, Elsevier: New York, 2015, pp. 15–54.
3. Banerjee, S., H. Shi, M. Banasik, H. Moon, W. Lees, Y. Qin, A. Harley, A. Shepherd, and M. W. Cho. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region. Virology 505:113–126, 2017.
4. Banerjee, S., H. Shi, H. H. Habte, Y. Qin, and M. W. Cho. Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure. Virology 490:17–26, 2016.
5. Bomsel, M., D. Tudor, A. S. Drillet, A. Alfsen, Y. Ganor, M. G. Roger, N. Mouz, M. Amacker, A. Chalifour, L. Diomede, G. Devillier, Z. Cong, Q. Wei, H. Gao, C. Qin, G. B. Yang, R. Zurbriggen, L. Lopalco, and S. Fleury. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34:269–280, 2011.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献